79 related articles for article (PubMed ID: 11184423)
21. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
23. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
24. Childhood-onset growth hormone (GH) deficiency in adult life.
Lissett CA; Shalet SM
Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):209-24. PubMed ID: 12064889
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone secretion in adult patients with thalassaemia.
La Rosa C; De Sanctis V; Mangiagli A; Mancuso M; Guardabasso V; Galati MC; Caruso-Nicoletti M
Clin Endocrinol (Oxf); 2005 Jun; 62(6):667-71. PubMed ID: 15943827
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
27. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
28. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
29. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone and the transition from puberty into adulthood.
Attanasio AF; Shalet SM
Endocrinol Metab Clin North Am; 2007 Mar; 36(1):187-201. PubMed ID: 17336740
[TBL] [Abstract][Full Text] [Related]
31. A lifetime of growth hormone deficiency: a US pediatric perspective.
Saenger P
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1337-42. PubMed ID: 11202206
[TBL] [Abstract][Full Text] [Related]
32. [Growth hormone deficiency in adults].
Krysiak R; Okopień B
Przegl Lek; 2007; 64(9):583-9. PubMed ID: 18510080
[TBL] [Abstract][Full Text] [Related]
33. Indications for GH replacement in adolescents and young adults.
Monson JP
J Endocrinol Invest; 2005; 28(5 Suppl):52-5. PubMed ID: 16114277
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone deficiency in adults and clinical use of recombinant human growth hormone.
Wang Z
Chin Med J (Engl); 1999 Mar; 112(3):195-201. PubMed ID: 11593547
[TBL] [Abstract][Full Text] [Related]
35. [Growth hormone deficiency in adults--clinical picture and treatment].
Christiansen JS; Jørgensen JO; Müller JR; Skakkebaek NE
Ugeskr Laeger; 1995 Jan; 157(4):428-32. PubMed ID: 7846786
[TBL] [Abstract][Full Text] [Related]
36. Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance.
Cázares-Delgadillo J; Ganem-Rondero A; Kalia YN
Eur J Pharm Biopharm; 2011 Jun; 78(2):278-88. PubMed ID: 21296662
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone coverage policy and implementation: a four-year experience.
Katz HP
HMO Pract; 1997 Jun; 11(2):68-73. PubMed ID: 10168111
[TBL] [Abstract][Full Text] [Related]
38. Is brain tumor recurrence increased following growth hormone treatment?
Moshang T
Trends Endocrinol Metab; 1995 Aug; 6(6):205-9. PubMed ID: 18406703
[TBL] [Abstract][Full Text] [Related]
39. The Gordon Wilson lecture: growth hormone--1966.
Astwood EB
Trans Am Clin Climatol Assoc; 1967; 78():94-106. PubMed ID: 5339084
[No Abstract] [Full Text] [Related]
40. Dr Mary Gordon.
Metz J
S Afr Med J; 2014 Oct; 104(11):7060. PubMed ID: 29183432
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
